학술논문
Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancer
Document Type
Article
Author
Source
In European Journal of Cancer July 2023 188:81-89
Subject
Language
ISSN
0959-8049